Clearance Summary
MODIFICATION TO BD ECLIPSE HYPODERMIC NEEDLE received FDA 510(k) clearance under submission number K043397, sponsored by Becton, Dickinson & CO. The device was reviewed via the Special premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2004-12-29.
- Submission: K043397
- Applicant / Sponsor: Becton, Dickinson & CO
- Clearance pathway: Special
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5570
- Decision date: 2004-12-29
Classification & Regulation
This clearance is catalogued under FDA product code FMI and 21 CFR 880.5570, within the General Hospital review panel as a Class II device.